333-350
Review
Fragile histidine triad protein: structure, function, and its association with tumorogenesis
Md. Imtaiyaz Hassan, Abdullah Naiyer and Faizan Ahmad
351-361
Orginal Paper
Changes in expression, and/or mutations in TGF-β receptors (TGF-β RI and TGF-β RII) and Smad 4 in human ovarian tumors
Marie Lue Antony, Rema Nair, Paul Sebastian and Devarajan Karunagaran
363-370
Original Paper
Disease-specific risk for an osteonecrosis of the jaw under bisphosphonate therapy
Tatjana I. Jung, Falk Hoffmann, Gerd Glaeske and Dieter Felsenberg
371-378
Original Paper
Efficacy of targeted therapy in patients with renal cell carcinoma with pre-existing or new bone metastases
Jakub Żołnierek, Pawel Nurzyński, Przemysław Langiewicz, Sylwia Oborska and Anna Waśko-Grabowska, et al.
379-386
Original Paper
Quality of life among elderly men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy
Shunichi Namiki, Shigeto Ishidoya, Sadafumu Kawamura, Tatsuo Tochigi and Yoichi Arai
387-394
Original Paper
Adenocarcinoma of the small bowel at a single Korean institute: management and prognosticators
Yong Wha Moon, Sun Young Rha, Sang Joon Shin, Hyun Chang and Hyo Sup Shim, et al.
395-401
Original Paper
SFRP4 was overexpressed in colorectal carcinoma
Dan Huang, Bin Yu, Yun Deng, Weiqi Sheng and Zhilei Peng, et al.
403-410
Original Paper
Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 status
Alexander Hoellein, Thomas Decker, Christian Bogner, Madlen Oelsner and Stefanie Hauswald, et al.
411-417
Original Paper
Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study
Cristiano Oliva, Paola Bergnolo, Manuela Inguì, Lavinia Bianco and Paolo Pochettino, et al.
419-426
Original Paper
Association of clinicopathological features with UbcH10 expression in colorectal cancer
Shimin Chen, Yingjian Chen, Chengjin Hu, Hongbiao Jing and Yongcheng Cao, et al.
427-435
Original Paper
Co-expression of survivin, c-erbB2, and cyclooxygenase-2 (COX-2): prognostic value and survival of endometrial cancer patients
Maria Lambropoulou, Nikolaos Papadopoulos, Grigoris Tripsianis, George Alexiadis and Olga Pagonopoulou, et al.
437-445
Original Paper
P53 and p38 MAPK pathways are involved in MONCPT-induced cell cycle G2/M arrest in human non-small cell lung cancer A549
Chong Zhang, Hong Zhu, Xiaochun Yang, Jianshu Lou and Difeng Zhu, et al.
447-456
Original Paper
Hypoxia induced paclitaxel resistance in human ovarian cancers via hypoxia-inducible factor 1α
Lei Huang, Qilin Ao, Qinghua Zhang, Xiaokui Yang and Hui Xing, et al.
457-464
Original Paper
Serum CA 125 expression as a tumor marker for diagnosis and monitoring the clinical course of epithelioid sarcoma
Makiko Hoshino, Hiroyuki Kawashima, Akira Ogose, Naoko Kudo and Takashi Ariizumi, et al.
465-473
Original Paper
Mina53, a novel c-Myc target gene, is frequently expressed in lung cancers and exerts oncogenic property in NIH/3T3 cells
Kazutoshi Komiya, Naoko Sueoka-Aragane, Akemi Sato, Takashi Hisatomi and Toru Sakuragi, et al.
475-481
Original Paper
Identification of potential serum markers for endometrial cancer using protein expression profiling
Masashi Takano, Yoshihiro Kikuchi, Takayoshi Asakawa, Tomoko Goto and Tsunekazu Kita, et al.